Archived Event
The Alliance Advancement Series
COVID Vaccines & Transplantation: Where Are We Now?
Presented on: Wednesday, November 30, 2022
Following the COVID-19 outbreak, all US citizens were encouraged to maximize protection efforts by getting all recommended vaccine doses and boosters, but there was concern about how the vaccine would affect the immunocompromised. For example, are there any special considerations for transplant recipients? During this webinar, we will welcome experts from Johns Hopkins and NYU Langone who will discuss the varying practices across the country and review what the outcome data shows thus far. Additionally, our panelists will discuss the impact of the new variants of COVID-19 on vaccine recommendations and monoclonal antibody associated immunoprotection.
- Summarize of the COVID-19 vaccine responses among transplant recipients
- Describe COVID-19 outcomes in the omicron era among transplant recipients
- Discuss the impact of new variants on vaccine and monoclonal antibody associated immunoprotection
National Innovation Forum Planning Committee, National Leadership & Innovation Council, NDMS 2021 Speaker, Speaker
Macey Levan
JD, PhD
Associate Professor of Surgery and Population Health
NYU Langone Health
Julie Anderson
MSN, MPH, RN, CCTC
Clinical Process Coordinator
Medical University of South Carolina
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.
Continuing Education Credits
Continuing Education credits are no longer available for this learning opportunity.
